DailyIQ
Last updated 1 hour ago

CTVA·Corteva, Inc.

$.
+. (+.%)
High
$81.00
Open
$79.46
Market Cap
53.21B
52W High
$85.63
Low
$79.09
P. Close
$79.56
P/E
45.79
52W Low
$60.53
Fwd P/E
35.75
Mean Target
-
Technical Score (1D)
77
BUY
News Sentiment
61
BULLISH
Corteva's earnings per share have seen a 13% year-over-year increase, reaching $1.87. This consistent profit growth is attracting investor attention, as sustained earnings are expected to drive long-term shareholder value. Investors are likely focusing on this fundamental strength as a positive indicator for the company's performance in the coming trading days.
Earnings Summary
Corteva, Inc. is a global agricultural company dedicated to providing farmers with innovative solutions for crop production, operating through its Seed and Crop Protection segments. The company develops advanced seed genetics and traits to optimize yields and enhance crop resistance, alongside offering a portfolio of herbicides and insecticides to protect crops and promote plant health. Corteva's products serve the agricultural input industry worldwide, with operations spanning major global regions. Analyzing Corteva's recent earnings, the company demonstrated an upward trend in both earnings per share (EPS) and revenue for the first two quarters of fiscal year 2025 compared to the preceding two quarters. Specifically, Q1 2025 saw EPS of $1.13 on revenue of $4.42 billion, followed by Q2 2025 with EPS of $2.20 on revenue of $6.46 billion. This contrasts with Q4 2024's EPS of $0.32 and Q3 2025's reported EPS of -$0.23. The company beat EPS estimates in Q4 2024, Q1 2025, and Q2 2025, but missed estimates in Q4 2025. Revenue figures are available for Q4 2024, Q1 2025, Q2 2025, Q4 2025, and Q1 2026, showing variability but a general increase in the most recent periods. Historically, Corteva has shown a mixed but generally positive year-over-year growth trajectory. The company has a pattern of beating analyst estimates for EPS in several recent quarters, including Q4 2024, Q1 2025, and Q2 2025, indicating strong operational execution. However, a notable miss occurred in Q4 2025, where actual EPS of $0.22 significantly trailed the estimate of $1.17. Despite this EPS miss, revenue for Q4 2025 was reported, though it fell short of estimates. The most recent quarter, Q1 2026, showed a strong beat on EPS ($1.50 actual vs. $1.18 estimate) and a revenue increase year-over-year. Recent news highlights Corteva's strategic developments and analyst sentiment. The company's management presented at the Global Farm to Market Conference, signaling a focus on strategic direction. Importantly, Corteva is undergoing a separation into two distinct entities: a crop protection business and a seed and genetics business, planned for Q4 2026. Bank of America reiterated a "Buy" rating and raised its price objective, citing a strong Q1 2026 earnings beat and reaffirmed full-year guidance. However, recent insider stock sales warrant attention, with some sales occurring near current market values. Looking ahead, investors will be watching for further details on the execution of the planned separation into two distinct companies, which is a significant strategic move. Key will be the operational performance and integration plans for both the crop protection and seed businesses as they move towards their respective headquarters. Additionally, continued adherence to reaffirmed full-year 2026 guidance following the Q1 beat will be crucial for maintaining investor confidence.

EPS

EstBeatMiss
$-0.87$0.01$0.88$1.75$2.63Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$2.23 - -
Q1'26$1.18$1.50+27.1%
Q4'25$1.17$0.22-81.3%
Q3'25$-0.47$-0.23+50.6%
Q2'25$1.88$2.20+17.1%
Q1'25$0.88$1.13+28.2%

Revenue

EstBeatMiss
$3.5B$4.4B$5.3B$6.2B$7.1BQ1'25Q2'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$6.7B - -
Q1'26$4.6B$4.9B+5.8%
Q4'25$4.6B$3.9B-15.8%
Q3'25 - - -
Q2'25 - $6.5B -
Q1'25 - $4.4B -

Market Data

CTVA Stock Snapshot

CTVA is currently trading at $79.68, giving Corteva, Inc. a market cap of 53.21B and a P/E ratio of 45.8. Today's range spans $79.09–$81.00, with shares opening at $79.46 and moving up $0.12 (0.2%) from the prior close. DailyIQ's technical score sits at 77/100 (BUY) with a news sentiment reading of 61/100.

Over the past year CTVA has traded between $60.53 and $85.63 - the current price is +31.6% off the 52-week low and -6.9% from the high.

The BUY technical setup for CTVA (77/100) is worth attention in the context of the broader Basic Materials sector. At $79.68 (in the upper portion of its 52-week range), with 53.21B in capitalization and bullish sentiment at 61/100 The current P/E ratio stands at 45.8., this large-cap name sits at the intersection where momentum strategies and fundamental growth investors both find something to like. Annual range: $60.53–$85.63.

The combination of a BUY signal (77/100) and bullish news sentiment (61/100) puts CTVA on the screens of active managers who run quality-momentum overlays — a cohort that can build meaningful positions at 53.21B in Basic Materials market cap without immediately moving the stock. At $79.68 (in the upper portion of its 52-week range in the $60.53–$85.63 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles
Loading latest news…